💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for CytRx Corporation (CYTR)
« Back to company indexCYTR Chatter Timeline
Stock Ticker for CYTR
Most Active Tweeters for CYTR
| User | Tweets |
|---|---|
| @michaeltomasi8 | 16 |
| @oasis_of_stocks | 3 |
| @FlashAlert_me | 2 |
| @ShortAlgoKing | 2 |
| @Traderideas1 | 1 |
Recent Tweets for CYTR
 |
@michaeltomasi8 @Biotech2k1 #10> $CYTR their drug Aldoxorubicin will replace doxorubicin worldwide & is being used in clinical tria… https://t.co/m578k4cwl4 January 17th 2021, 9:01pm |
 |
@MarcJacksonLA $CYTR CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival… https://t.co/WDyVLltbzh January 15th 2021, 3:01pm |
 |
@pablodesaavedra CytRx highlights positive data from phase 2 QUILT 88 trials in pancreatic cancer patients $cytr #aldoxorubicin… https://t.co/4DZcVdxmDd January 15th 2021, 2:01pm |
 |
@otc_watch_news $CYTR #OTCQB CytRx Corp. (CYTR: OTCQB) | CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding… https://t.co/NCUqVASyrt January 15th 2021, 1:01pm |
 |
@FlashAlert_me $CYTR [15s. delayed]: Issued Press Release on January 15, 08:00:00: CytRx Highlights Use of Aldoxorubicin in Phase… https://t.co/xX8KVU8uKJ January 15th 2021, 1:01pm |
 |
@stock_titan $CYTR CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival R… https://t.co/0M8nppZ2Ez January 15th 2021, 1:01pm |
 |
@Traderideas1 $CYTR CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival R… https://t.co/vZ1kLdYOKr January 15th 2021, 1:01pm |
 |
@ShortAlgoKing $CYTR Tried to warn you! So much easier to trade with the Buy / Short signals. Get access to ShortAlgo for simplifi… https://t.co/WXqr5Kp6ar January 14th 2021, 6:01pm |
|
@ShortAlgoKing $CYTR [Short Alert] Signals could not be any clearer on the 5-minute chart of CYTR with the entry / exit indicators… https://t.co/SgpUN3nGWm January 14th 2021, 6:01pm |
|
@michaeltomasi8 when the mystery is revealed & truth comes out: Dr. Daniel Levitt MD did not blow a whistle at $CYTR about Steven K… https://t.co/iPWWAVFPxZ January 14th 2021, 2:01pm |
|
@michaeltomasi8 @JohnCendpts @ka_blankenship I suggested to Mark might that he want to take a look at $CYTR bcuz their drug Aldoxor… https://t.co/4462E04xZ3 January 14th 2021, 1:01pm |
|
@michaeltomasi8 When you wake up in the morning and find out $CYTR is $30 per share: just remember they should have filed the NDA f… https://t.co/Wa1YcBVBcK January 13th 2021, 11:01pm |
 |
@oasis_of_stocks Watching $CYTR if it breaks 2s area imo January 13th 2021, 5:01pm |
|
@michaeltomasi8 @Pharmdca $CYTR Arimoclomol, Aldoxorubicin will replace doxorubicin worldwide: this will be the biggest change in c… https://t.co/d7mg8hdNKk January 13th 2021, 10:01am |
|
@oasis_of_stocks $CYTR is ready to break 2s imo January 12th 2021, 7:01pm |
|
@oasis_of_stocks $CYTR on watch for 2 break ; holding some as a swing play January 12th 2021, 5:01pm |
|
@michaeltomasi8 $CYTR We also agree in Mr. Caloz’s employment agreement that if we do not offer to renew or extend the agreedment w… https://t.co/5xl3gMPqCK January 8th 2021, 12:01pm |
 |
@marketexclusive $CYTR CYTRX CORPORATION (NASDAQ:CYTR) Files An 8-K Departure of Directors or Certain Officers; Election of Directo… https://t.co/uy5MwBriNC January 8th 2021, 9:01am |
|
@michaeltomasi8 @davidfaber @adamfeuerstein Did Feuerstein's [planned] attack on $CYTR Aldoxorubicin help to save $CELG Abraxane 4… https://t.co/mHied4EXqE January 8th 2021, 7:01am |
 |
@fintel_io $CYTR / CytRx files form 8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce… https://t.co/jkfL43QPOK January 8th 2021, 6:01am |
 |
@EdgarInsider A Form 8-K [Press/News Current Report] filing has been made with the SEC: $CYTR CYTRX CORP https://t.co/KdlYLUqnvb January 8th 2021, 6:01am |
|
@FlashAlert_me $CYTR [15s. delayed] filed form 8-K on January 08, 06:08:04 https://t.co/pub1jiXirY January 8th 2021, 6:01am |
 |
@ScryingBiotech Initiated a starter position in another maligned biotech $CYTR at $1.50 per share (5.5k shares). A proxy filing set… https://t.co/dkMdTawlie January 7th 2021, 2:01pm |
|
@michaeltomasi8 @SquawkStreet @adamfeuerstein By omitting public reference to the inventor Dr. Felix Kratz & company $CYTR behind c… https://t.co/3SSRDG2xgo January 7th 2021, 5:01am |
|
@michaeltomasi8 @SquawkStreet By omitting public reference to the inventor Dr. Felix Kratz & company $CYTR behind chemotherapeutic… https://t.co/FFjqJZJxbc January 7th 2021, 5:01am |
|
@michaeltomasi8 Who tipped Adam Feuerstein off to $CYTR's public offering that he clearly targeted a painful blow to the stock pric… https://t.co/FD3IwzARM1 January 7th 2021, 12:01am |
|
@michaeltomasi8 @adamfeuerstein 's tweet on April 17, 2017 ensured catastrophe for the stock price of $CYTR w/ Feuerstein's negativ… https://t.co/Bagw90NiL9 January 7th 2021, 12:01am |
|
@michaeltomasi8 @davidfaber @SquawkStreet Dr. Patrick Soon Shiong Nantcell stepped in & prevented $CYTR from filing NDA 2017 for Al… https://t.co/ctePQ3qyVw January 6th 2021, 5:01am |
|
@michaeltomasi8 @davidfaber @SquawkStreet The FDA had 40 years of data on doxorubicin. FDA knew $CYTR 's Aldoxorubicin was working… https://t.co/rApJ2MvIY5 January 6th 2021, 5:01am |
|
@michaeltomasi8 @adamfeuerstein they intentionally dropped $CYTR off of Nasdaq bcuz it prevented scrutiny, hid the gem Aldoxorubici… https://t.co/mif69WySWl January 6th 2021, 4:01am |
|
@michaeltomasi8 @adamfeuerstein you were right Adam, but for the wrong reasons. $CYTR did an offering to keep the stock price under… https://t.co/P8pzQ3g6f3 January 6th 2021, 4:01am |
|
@michaeltomasi8 @adamfeuerstein keep $CYTR UNDER $1, “Following extensive due diligence and careful consideration, the CytRx manage… https://t.co/v7zLQFqARw January 6th 2021, 4:01am |
 |
@geeft_iredia RT @OddStockTrader: Check out this $CYTR chart... https://t.co/gJLBc875nU January 4th 2021, 7:01pm |
 |
@FlyOnTheWallHQ $CYTR to get massive exposure following next weeks scheduled segment on CNBC Squawk Box https://t.co/fK8PPZ6hwp… https://t.co/IyvWBfhY5W January 2nd 2021, 10:01pm |
|
@MarcJacksonLA $CYTR CytRx Issues Statement Regarding U.S. Regulatory Review of Arimoclomol for Niemann-Pick Disease Type C | Busi… https://t.co/V3IW7Xl9gp January 1st 2021, 9:01am |
 |
@equity_newswire $CYTR CytRx Issues Statement Regarding U.S. Regulatory Review of Arimoclomol for Niemann-Pick Disease Type C https://t.co/OupfYupSIY December 31st 2020, 3:12pm |
 |
@newsfilterio CytRx announces FDA extension of review for rare disease therapy $CYTR $ORPH https://t.co/37WrwtvpzZ December 31st 2020, 3:12pm |
 |
@sbwcws CytRx says Orphazyme's arimoclomol PDUFA target date extended to June 17, 2021 $CYTR $ORPH December 31st 2020, 2:12pm |
 |
@otcdynamics $CYTR CytRx Issues Statement Regarding U.S. Regulatory Review of Arimoclomol for Niemann-Pick Disease Type C https://t.co/CptZnAdMRd December 31st 2020, 2:12pm |
 |
@Traderideas1 $CYTR CytRx Issues Statement Regarding U.S. Regulatory Review of Arimoclomol for Niemann-Pick Disease Type C December 31st 2020, 2:12pm |
|
@stock_titan $CYTR $ORPH CytRx Issues Statement Regarding U.S. Regulatory Review of Arimoclomol for Niemann-Pick Disease Type C https://t.co/tzkZvkbifY December 31st 2020, 2:12pm |
 |
@rita_budai $CYTR Happy New Year! ?? December 31st 2020, 12:12pm |
 |
@KashZani $CYTR ? PROFITS TAKEN I sold the rest of my $CYTR and have completely excited the trade. I sold some last time f… https://t.co/khpr79gTI2 December 29th 2020, 9:12pm |
|
@rita_budai $CYTR my favorite bull! https://t.co/IthYm71RNP December 29th 2020, 11:12am |
|
@oasis_of_stocks $CYTR watching for 2.18s area next imo December 29th 2020, 10:12am |
|
@oasis_of_stocks $CYTR might be ready to get to higher levels imo. Check the chart imo : https://t.co/6dJhLnCpS1 December 29th 2020, 10:12am |
|
@oasis_of_stocks $CYTR approaching 2s break December 29th 2020, 9:12am |
 |
@ScotchStocks $CYTR - Has had a crazy run. December 29th 2020, 9:12am |
 |
@zlinst28 Buy this stock if you like free money. I'll pay you back personally if you don't #CYTR $CYTR https://t.co/ADkwjsJ9XQ December 25th 2020, 5:12am |
 |
@Alexs_trades $CYTR beauty adds the other day https://t.co/LkXUiWoBSm https://t.co/COFVBl8WS1 December 24th 2020, 10:12am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
